Subramanian Sanjay 4
4 · Inozyme Pharma, Inc. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Subramanian Sanjay
SVP, CFO & Head of BD
Transactions
- Award
Stock option (right to buy)
2023-03-23+135,000→ 135,000 totalExercise: $3.30Exp: 2033-03-22→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 23, 2023. The shares underlying the option are scheduled to vest in equal monthly installments from April 23, 2023 through March 23, 2027.